KITLG and atrial fibrillation: Both groups have concluded that the sensitivity of AF to imatinib requires an alternative explanation and possibly involves an autocrine mechanism, possibly associated with a hypersensitivity to SCF, related to the induction of a ligand-independent dimerisation induced by the exon 10 variant.